Communities of practice
Leprosy is occasionally known as Hansen’s disease, after Armauer Hansen, the Norwegian physician who first identified the microorganism which causes the disease. Known and dreaded since biblical times because of the severe deformities that can occur, it was considered incurable until as recently as the 1940s.
2 Jun 2010
When interventions are planned, insufficient thought is given as to whether the poorest and most vulnerable members of society will benefit, according to the findings of a new review of the evidence. The reviewers call for more research to assess which infectious disease programmes benefit the poor and to identify the mechanisms that determine “pro-poor effectiveness”.
29 Jan 2010
There are still a quarter of a million new cases every year. A leading specialist says that leprosy research – but not leprosy – has been “eliminated”.
18 Nov 2010
What is the place for research in global efforts to control neglected tropical diseases?
28 May 2010
Access to data from the G-FINDER survey will help funders and product developers better understand where funding gaps lie and how their investments fit into the global picture.
24 Feb 2011
The latest G-FINDER report says that funding for basic scientific research has increased but finances available for product development have fallen. How can funders determine where the greatest needs lie and work more closely together?
20 May 2010
So far in the 21st century (and with the exception of malaria and AIDS), only four new products have become available for treating or preventing infections in poor communities.
10 Jul 2009
BCG vaccination is still widely given in many parts of the world but a study confirms that its use may harm those children who are HIV infected.
18 Dec 2009
The global budget for research into the infectious diseases of poverty is little changed and AIDS continues to receive a disproportionately large share of the total. But India and Brazil are emerging as key players, particular for the more neglected diseases.
8 May 2009
Is your organisation working against the infectious diseases of poverty?